ARAY241115P2000
- 0.05
- 0.000.00%
Accuray Newsroom
Lake Street Maintains Accuray(ARAY.US) With Buy Rating, Maintains Target Price $6
Lake Street Maintains Accuray(ARAY.US) With Buy Rating, Maintains Target Price $6
Lake Street Keeps Their Buy Rating on Accuray (ARAY)
Lake Street Maintains Accuray(ARAY.US) With Buy Rating, Maintains Target Price $6
Lake Street Remains a Buy on Accuray (ARAY)
Roth MKM Maintains Accuray(ARAY.US) With Buy Rating, Maintains Target Price $7
Accuray (ARAY) Receives a Buy From Roth MKM
BTIG Maintains Accuray(ARAY.US) With Buy Rating, Maintains Target Price $6
Accuray (ARAY) Gets a Buy From Lake Street
Accuray's Buy Rating Affirmed Despite Challenges, With Positive Long-Term Growth and Overseas Market Expansion
Accuray Analyst Ratings
Accuray (ARAY) Gets a Buy From Lake Street
BTIG Keeps Their Buy Rating on Accuray (ARAY)
Analysts Offer Insights on Healthcare Companies: CVS Health (CVS), UnitedHealth (UNH) and Accuray (ARAY)
Accuray's Stock Potential: An In-depth Analysis of Its Buy Rating Based on Updated F24 Guidance
B. Riley Trims Accuray's Price Target to $6.50 From $7.50 on Lower Multiple, Maintains Buy Rating
Analysts' Top Healthcare Picks: Accuray (ARAY), Gritstone Oncology (GRTS)
TD Cowen Keeps Their Buy Rating on Accuray (ARAY)
Accuray (ARAY) Gets a Buy From Lake Street
Strong Financial Performance and Future Catalysts Bolster Buy Rating for Accuray: An Analysis by Marie Thibault